“…Of the 18 studies that reported VTE outcomes and antepartum LMWH prophylaxis use, there were 0 antepartum VTE events among 82 pregnancies with LMWH use (0%; 95% CI, 0.0-5.7; I 2 0%), and 8 antepartum VTE events among 407 pregnancies without LMWH use (2.5%; 95% CI, 1.3-4.3; I 2 0%) ( Table 2). [4][5][6][7][14][15][16][17][18][19][20][21][22][23]25,[28][29][30][31] Among the 18 studies that reported VTE outcomes and ASA use during pregnancy, there were 6 antepartum VTE events among 283 pregnancies with ASA use (2.9%; 95% CI, 1.3-5.1; I 2 0%), and 2 antepartum VTE events among 158 pregnancies without ASA use (2.8%; 95% CI, 0.9-5.8; I 2 0%). Of the subgroup of 212 pregnancies reported in which ASA was used alone without LMWH, there were 6 antepartum VTE events (4.2%; 95% CI, 2.0-7.1; I 2 0%).…”